Physician profile
Charn S Nandra
NPI 1558358317
$795.11
in general payments reported to CMS, 2019-2025
16 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.44 · 2022: $40.82 · 2023: $129 · 2024: $68.51 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.96 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $199.27 | 2024-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $165.24 | 2019-2025 | Farxiga, Andexxa, Wainua |
| E.R. Squibb & Sons, L.L.C. | $97.56 | 2019-2024 | Camzyos |
| Novo Nordisk INC | $76.46 | 2022-2025 | Wegovy |
| Abiomed | $39.45 | 2025 | |
| Merck Sharp & Dohme LLC | $30.98 | 2023 | Verquvo |
| Boston Scientific Corporation | $30.86 | 2025 | Watchman Access System |
| Cardiva Medical, INC. | $30.67 | 2025 | Savvywire |
| Lexicon Pharmaceuticals, INC. | $19.42 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $19.19 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.06 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.56 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $15.21 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.74 | 2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $12.74 | 2023 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $10.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charn Nandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.